Team Collaboration​

Collaboration with Yiye-China​

Through the statistical analysis and screening of various iGEM teams in China, we have initially identified Yiye-China, a team with a similar research focus. Our team firmly believes that "1+1>2," and we are confident that collaborating with them will lead to a win-win situation through mutual exchange and exploration.

At the beginning of August, the two teams engaged in an in-depth discussion regarding project work plans and current progress. We gained a fundamental understanding of each other's experimental goals and preliminary solutions, and we conducted a comprehensive horizontal comparison and in-depth analysis of the project contents from multiple perspectives and dimensions.

During the meeting, BUCT-China 2024 first provided an overview of MicroDetect, sharing our ideas regarding the work plan, including our focus on HP. We were pleased to find that Yiye-China was very supportive of our ideas. Subsequently, they shared their completed work progress and next steps using a mind map. Through our discussions with them, we learned many valuable insights and tips for various stages of project work, which provided us with creative and practical inspiration. After the exchange, our team conducted a brief brainstorming session, allowing us to promptly and efficiently initiate and complete our tasks.

In summary, this exchange has provided us with a clearer roadmap for our upcoming work. We are grateful for Yiye-China's active interaction and sharing, and we look forward to achieving mutual progress through ongoing collaborations.

Collaboration with Hangzhou-MedX​

(Collaboration with Hangzhou-MedX, Shanghai-BioX, Hangzhou-SDG, HW-ShanghaiUnited, Squirrel-Shanghai, Jiangnan-China, BNDS-China, NEFU-China, iZJU-China and BIT-China)

BUCT-China 2024 successfully participated in an online popular science live streaming event titled "Synthetic Biology and Applications" in collaboration with ten other teams from across China. The event aimed to educate the public about synthetic biology, spark interest in life sciences, and promote the dissemination and exchange of scientific knowledge through an online platform.

Over 10 teams presented their projects, covering various aspects of synthetic biology, including its definition, development history, cutting-edge technologies, and potential applications. Themes included the applications and research achievements of synthetic biology in fields such as medicine, agriculture, and environmental protection. Each team utilized formats like PowerPoint presentations and videos to vividly showcase the charm and potential of synthetic biology, offering the audience an exciting scientific feast. During the outreach process, viewers raised questions through bullet comments or chatrooms, which were answered by the presenters, enhancing the interactivity and engagement of the event.

The event attracted over 3,700 participants, including students, teachers, researchers, and biology enthusiasts. By utilizing an online platform, the event transcended geographical barriers, allowing more individuals to engage with and learn about synthetic biology. This successful event effectively popularized the fundamental concepts and latest advancements in synthetic biology to the public, sparking interest and enthusiasm for life sciences.

This online outreach activity on synthetic biology was a resounding success, not only providing a platform for the public to understand synthetic biology but also igniting their interest and passion for life sciences. In the future, BUCT-China 2024 will continue to organize similar online outreach activities, constantly innovating and enriching the content while strengthening collaboration with other teams to promote the dissemination of synthetic biology knowledge. We also look forward to greater public participation in science outreach, collectively contributing to the construction of a better ecological future.

Collaboration with NAU-China, NWU-CHINA-A and AFMU-China​

The founding purpose of the journal Gene Whimsy is to create a platform that combines depth, focus, and longevity, aiming to disseminate the latest advancements in synthetic biology and precision medicine to a broad non-specialist audience. The magazine conveys complex scientific concepts in an engaging and easily understandable manner through thoughtfully designed visuals and content, committed to educating and inspiring the public.

BUCT-China 2024 collaborates with AFMU-China, NWU-CHINA-A and NAU-China to explore innovative treatment solutions for significant diseases, including type 2 diabetes and Mucopolysaccharidosis type II. These teams leverage cutting-edge technologies like engineered lactobacilli and functional exosomes to demonstrate the tremendous potential of synthetic biology in disease treatment.

AFMU-China has effectively reduced the treatment burden of type 2 diabetes through the synthetic biological modification of lactobacilli. NWU-CHINA-A has developed exosomes capable of penetrating the blood-brain barrier for the rare disease MPS II, opening new therapeutic avenues for patients. NAU-China emphasizes the global impact of synthetic biology, highlighting its central role in addressing worldwide challenges.

Our work reflects not only the depth and breadth of scientific exploration but also the scientists' profound concern for human health. Through educational and public engagement activities, we enhance public awareness of the importance of synthetic biology and promote the dissemination of scientific knowledge. At the same time, our collaboration with international organizations and patients transcends geographical and cultural boundaries, working together to build a healthier and more sustainable future.

We also embrace social responsibility, focusing on the actual needs of patients and respecting the uniqueness of each individual as a starting point for driving innovation in medical models. Our work demonstrates that synthetic biology can not only bring hope to patients but also have a profound impact on society.

Through the medium of the magazine, we aim to spark readers' interest in science, improve their scientific literacy, and promote the dissemination of scientific knowledge. We believe this will help establish a community for scientific exchange, encouraging more people to participate in discussions and practices related to synthetic biology and precision medicine, collectively advancing scientific progress and human health.

Collaboration with LZU-China, NAU-China, NWU-CHINA-A and AFMU-China​

Compared to traditional written science communication, podcasts are more vivid and intuitive through sound, allowing listeners to tune in anytime and anywhere. They make use of fragmented time without requiring long periods of reading, aligning with the fast-paced lifestyle of contemporary society. Podcasts can reach a broader audience, including those who may not actively engage in learning about cutting-edge biological technologies and individuals with visual impairments. By explaining complex concepts through relaxed, conversational dialogue, podcasts facilitate understanding among the general public. They can break down barriers related to time, space, and economic conditions, enabling more people to easily access scientific knowledge and enhance their scientific literacy in daily life.

BUCT-China 2024 collaborates with four teams—LZU-China, NAU-China, NWU-CHINA-A, and AFMU-China—inviting them as guests to engage in discussions that allow listeners to gain a deeper understanding of each team's projects this year. Additionally, we have produced a series titled “Synthetic Biology in Everyday Life”, which explores topics closely related to daily life, such as lung cancer, infant formula, and lab-grown meat. This series scientifically analyzes the issues surrounding these topics and highlights the applications of synthetic biology, enabling listeners to address real-life problems while learning about synthetic biology.

Our target audience is not professionals but the general public. We aim for our podcast to address everyday questions from a scientific perspective while introducing cutting-edge technological applications, allowing listeners to easily grasp the knowledge of synthetic biology. The podcast showcases various applications of synthetic biology across different fields, including biomanufacturing, diagnostics, therapy, food, and agriculture, discussing them through familiar everyday contexts.

Collaboration with JLU-NBBMS & XJTLU-SOFTWARE​

(Collaboration with JLU-NBBMS, XJTLU-SOFTWARE, BNUZH-China, Guangxi-U-China, JLU-CP, HKUST-GZ, OUC-Haide, PekingHSC, SCUT-China-S, SMU-China, SZU-China, UM-iGEM, XJTLU-CHINA, NJU-China, SJTU-Software and USTC-Software)

This year, we collaborated with 17 other teams in China to write a white paper on biosafety and bioethics in synthetic biology.

Collaboration with BIT-China​

(Collaboration with BIT-China, NWU-CHINA-A, iZJU-China, Fudan, SZPU-China)

This year, we collaborated with 5 other teams in China to write a handbook on sustainable development goals in synthetic biology.

Individual Collaboration​

BUCT-China 2024 is fortunate to once again collaborate with Dr. Li Xu and Dr. Yahui Lin as we embark on this extraordinary journey in iGEM this year. The spark of our initial encounter last year has now blossomed into a brilliant flame of cooperation, illuminating every step of our exploration into the frontiers of biomedicine.

Every weekend, while most people indulge in leisure time, our team becomes exceptionally active thanks to the deep involvement of Dr. Xu and Dr. Lin. Whether it’s an online conference or a meticulously organized workshop, both doctors consistently join us punctually, infusing our project with a continuous flow of inspiration and motivation drawn from their extensive clinical experience and forward-looking perspectives.

In front of the screen, the two doctors share the latest clinical research findings and provide invaluable insights into key issues within the project. Each interaction feels like a gentle spring breeze, allowing complex problems to be resolved effortlessly. When conditions permit, we also organize in-person seminars on weekends, where both doctors personally attend to engage in face-to-face discussions with team members. From case analyses to technical operations, they not only impart professional knowledge but also exemplify the brilliance of a compassionate healer. Their thoughtful guidance leaves a profound impact in every corner of our laboratory.

This extraordinary level of dedication and collaboration has not only led to significant advancements in our clinical research but has also inadvertently built a bridge connecting theory and practice. The passion and commitment of Dr. Xu and Dr. Lin to the medical field deeply inspire every team member, igniting a spirit of continuous exploration and innovation.

Looking ahead, we are filled with confidence and anticipation. Both doctors have made it clear that they will continue to be our strongest support, working hand in hand to tackle more clinical challenges and promote innovative development in the medical field. We believe that through our close collaboration, we will be able to create more health solutions that benefit patients and lead the future.

Institutional Collaboration​

In this season filled with hope, BUCT-China 2024 embarked on a journey of exploration and exchange, with footprints spanning the academic halls of Beijing Ritan High School, the innovative frontiers of Shenzhen Bay Laboratory, the industrial hub of Lunan Pharmaceutical, and the medical high ground of the China-Japan Friendship Hospital. Each in-depth exchange not only deepened our understanding of various fields but also garnered enthusiastic responses and sincere invitations from all sectors, collaboratively painting beautiful blueprints for win-win cooperation.

At Beijing Ritan High School, we engaged in discussions with teachers and students about educational innovation and the cultivation of future talent. Through a series of vibrant academic lectures and interactive workshops, we shared the latest achievements of our project in interdisciplinary integration, igniting students' passion for scientific exploration. The school leadership highly praised our visit and expressed hopes for future outreach activities aimed at young people, aiming to cultivate more future leaders equipped with innovative thinking and social responsibility.

Shenzhen Bay Laboratory, a fertile ground for scientific innovation, witnessed deep dialogues between BUCT-China 2024 and top scientists. From cutting-edge gene editing technologies to the latest advancements in biomedicine, each collision of ideas shone with the brilliance of science and technology. The laboratory's leadership fully recognized our professional capabilities and the project's prospects, expressing a strong willingness to collaborate, hoping to engage in closer cooperation in joint research project applications, technological achievements transformation, and other areas to jointly promote scientific progress and social development.

Entering Lunan Pharmaceutical, BUCT-China 2024 profoundly felt the synergistic power of industry and research. Through on-site visits and thematic seminars, we engaged in in-depth discussions with senior management and R&D teams regarding drug development and production process optimization. Both parties initiated preliminary discussions on potential collaborative projects, including new drug development partnerships and clinical trial support, showcasing the vast prospects of deep integration between research and industry. Lunan Pharmaceutical expressed eagerness to establish a long-term and stable partnership with our team to jointly promote innovation and development in the pharmaceutical industry.

Revisiting the familiar grounds of the China-Japan Friendship Hospital, BUCT-China 2024 felt the warmth and welcome of an old friend. The successful collaborative experience from last year laid a solid foundation for us, and this year we engaged in deeper exchanges centered around medical technology innovation and clinical case sharing. The hospital's leadership and expert team highly evaluated our work and clearly stated their continued support for our team's exploration and practice in the medical field. Both sides engaged in in-depth discussions about future cooperation directions, including co-hosting international academic conferences and developing telemedicine collaborations, showcasing a firm determination to work hand in hand toward a shared future.

Four regions, four gains; each affirmation serves as the greatest encouragement and motivation for BUCT-China 2024. We understand that only by maintaining an open and inclusive mindset and actively seeking cooperation opportunities with various types and levels of institutions can we continuously broaden the boundaries and depth of our project. Looking ahead, we will continue to uphold the concept of win-win cooperation, working hand in hand with partners from all sectors to create an even more brilliant tomorrow!